B2849 - Perinatal CMV Infection and Childrens Cognitive Development - 14/11/2018

B number: 
B2849
Principal applicant name: 
Rayjean Hung | Lunenfeld-Tanenbaum Research Institute, Sinai Health System, University of Toronto (Canada)
Co-applicants: 
Dr. Kelly Murphy, Dr. Tony Mazzulli, Dr. Jennifer Jenkins, Dr. Ruth Mitchell , Dr. Caroline Relton
Title of project: 
Perinatal CMV Infection and Children’s Cognitive Development
Proposal summary: 
Impact of research: 
CMV represents a substantial but under-studied public health issue. This research will help to answer two research questions that have major public health impact: (i) What is the long-term effect of CMV infection during the perinatal period on children’s cognitive function? And (ii) do children’s health sequelae differ by mother’s or children’s genetic profile, particularly the genetic variations in the immune response and inflammation pathways? The results of this project will shape the management strategy of CMV during the perinatal period. Furthermore, understanding the host genetic control may help to identify the vulnerable population for target surveillance
Date proposal received: 
Friday, 26 October, 2018
Date proposal approved: 
Tuesday, 30 October, 2018
Keywords: 
Epidemiology, Developmental disorders - autism, Cognitive impairment, GWAS, CMV assay, Methylation asay, Infection, Epigenetics